Latest Insider Transactions at Theravance Biopharma, Inc. (TBPH)
This section provides a real-time view of insider transactions for Theravance Biopharma, Inc. (TBPH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Theravance Biopharma, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Theravance Biopharma, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 20
2020
|
Ann Brady PRESIDENT, TBIL |
SELL
Payment of exercise price or tax liability
|
Direct |
2,292
-2.28%
|
$38,964
$17.21 P/Share
|
|
Nov 20
2020
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
SELL
Payment of exercise price or tax liability
|
Direct |
3,876
-2.87%
|
$65,892
$17.21 P/Share
|
|
Nov 20
2020
|
Brett K Haumann Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,639
-1.64%
|
$78,863
$17.21 P/Share
|
|
Nov 20
2020
|
Frank Pasqualone SVP, CHIEF BUSINESS OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,214
-1.04%
|
$71,638
$17.21 P/Share
|
|
Nov 20
2020
|
Kenneth R Pitzer SVP, PROD STRAT & COMM PLNG |
SELL
Payment of exercise price or tax liability
|
Direct |
4,807
-1.41%
|
$81,719
$17.21 P/Share
|
|
Nov 20
2020
|
Vijay Sabesan SVP, TECHNICAL OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
3,798
-1.93%
|
$64,566
$17.21 P/Share
|
|
Nov 20
2020
|
Bradford J Shafer EVP, Gen. Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,807
-1.87%
|
$81,719
$17.21 P/Share
|
|
Nov 20
2020
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
13,946
-1.08%
|
$237,082
$17.21 P/Share
|
|
Nov 20
2020
|
Philip D Worboys SVP, RESEARCH & TRANSL SCIENCE |
SELL
Payment of exercise price or tax liability
|
Direct |
4,807
-1.46%
|
$81,719
$17.21 P/Share
|